This year we found out exactly what the market’s true appetites were. I am happy to report that a thorough inspection of the global (re)insurance street’s refuse shows that these appetites are healthy.
In this GCP Short, produced in partnership with MAXIS Global Benefits Network, we explore findings from the network's latest whitepaper on GLP-1s, often known as weight-loss drugs.
Richard is joined by Mat Robinson, Senior Managing Director and Captive Operations Leader, and Matt Gravelin, Managing Director in Consulting at Brown & Brown, to discuss how organisations can hone their captive strategy and achieve strong internal buy-in from across the group.
